-
Biosight Receives Orphan Drug Designation for BST-236 for AML
americanpharmaceuticalreview
June 06, 2019
Biosight announced the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to BST-236, an investigational novel antimetabolite, for the treatment of acute myeloid leukemia (AML).
-
FDA approves first drug for episodic cluster headaches
pharmaceutical-technology
June 06, 2019
Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm) for episodic cluster headache in adults.
-
New partnership established to track drugs using blockchain
europeanpharmaceuticalreview
June 05, 2019
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
-
Health Tip: Over-the-Counter Drugs That Don't Mix With Alcohol
drugs
June 05, 2019
Over-the-Counter Drugs That Don't Mix With Alcohol.
-
WHO announces support for drug pricing transparency
drugs
June 03, 2019
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
-
Scientists Develop an Antibiotic Alternative Against 'Superbugs'
drugs
May 30, 2019
Scientists Develop an Antibiotic Alternative Against 'Superbugs'.
-
Sermonix Receives FDA Fast Track Designation for Investigational Drug Lasofoxifene
drugs
May 30, 2019
Sermonix Receives FDA Fast Track Designation for Investigational Drug Lasofoxifene.
-
Retail prices on several anti-cancer medications slashed
europeanpharmaceuticalreview
May 30, 2019
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
-
Though 'Donut Hole' Is Shrinking, Medicare Drug Costs Are Rising: Study
drugs
May 29, 2019
Though 'Donut Hole' Is Shrinking, Medicare Drug Costs Are Rising.
-
Rising Rx Drug Costs Continue to Create Tough Choices for Seniors
drugs
May 23, 2019
A solid minority of senior citizens still struggles to afford their prescription medications, a new government report shows.